(Q28236008)

English

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

scientific article (publication date: 15 April 2006)

In more languages

Statements

scholarly article

0 references

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eduardo L. Franco

object named as

Eduardo L Franco

2

0 references

Cosette M Wheeler

3

object named as

Cosette M Wheeler

0 references

author name string

Diane M Harper

1

0 references

Anna-Barbara Moscicki

4

0 references

Barbara Romanowski

5

0 references

Cecilia M Roteli-Martins

6

0 references

David Jenkins

7

0 references

Anne Schuind

8

0 references

Sue Ann Costa Clemens

9

0 references

Gary Dubin

10

0 references

language of work or name

0 references

publication date

15 April 2006

0 references

0 references

367

0 references

9518

0 references

1247-55

0 references

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide burden of gynaecological cancer: the size of the problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinogenicity of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

On the design and analysis of randomized clinical trials with multiple endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and other milestones for human papillomavirus vaccine introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seroresponses to virus-like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San people of Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968439-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)68439-0

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28236008&oldid=1430825147"